Pharmaceuticals

Projected Growth of the Global Kidney Fibrosis Treatment Market to Reach $8.21 Billion by 2029

December 4, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the kidney fibrosis treatment market from 2025–2034 with trusted insights from The Business Research Company

What CAGR And Valuation Are Anticipated For The Kidney Fibrosis Treatment Market By The End Of 2029?

The kidney fibrosis treatment market size has experienced robust growth in recent years. It is projected to expand from $5.62 billion in 2024 to $6.06 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.8%. This historical expansion can be attributed to several factors, including heightened research and development investments in fibrosis-targeting therapies, increased government funding for kidney disease management initiatives, growing patient awareness of kidney transplantation and fibrosis treatment options, expanding healthcare infrastructure, and the rising prevalence of aging populations.

The kidney fibrosis treatment market size is anticipated to experience substantial growth over the next few years, reaching “$8.21 billion by 2029 at a compound annual growth rate (CAGR) of 7.9%.” This expansion during the forecast period is attributable to the increasing occurrence of chronic kidney diseases, a growing need for advanced therapies for managing renal fibrosis, heightened awareness of early-stage kidney fibrosis diagnosis, the expanding adoption of personalized medicine in kidney disease treatment, and the rising rates of diabetes and hypertension. Major trends expected in the forecast period include technological advancements in early detection and diagnostic tools, progress in gene therapy, the integration of technology in telemedicine and remote monitoring, breakthroughs in stem cell therapies, and innovations in drug delivery systems.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24271&type=smp

Which Business Drivers Are Underpinning The Growth Of The Kidney Fibrosis Treatment Market?

The rising occurrence of chronic kidney diseases is projected to drive expansion within the kidney fibrosis treatment market in the coming years. Chronic kidney disease (CKD) involves a progressive decline in kidney function over time, frequently stemming from conditions like diabetes or high blood pressure, leading to a buildup of waste materials in the body. The growing incidence of chronic kidney disease (CKD) is primarily fueled by increasing diabetes rates, which harm kidney blood vessels and compromise their capacity to filter. Treatment for kidney fibrosis aids chronic kidney disease (CKD) patients by addressing the scarring of renal tissue, lessening inflammation, and decelerating the advance of kidney damage, thereby preserving kidney function. For example, in May 2024, data from the Centers for Disease Control and Prevention (CDC), a US-based public health agency, indicated that an estimated 14% of U.S. adults, or approximately 35.5 million people, are thought to be suffering from chronic kidney diseases. Consequently, the rising prevalence of chronic kidney diseases is stimulating the expansion of the kidney fibrosis treatment market.

What Are The Principal Segment Types In The Kidney Fibrosis Treatment Market?

The kidney fibrosis treatment market covered in this report is segmented –

1) By Treatment Type: Angiotensin-Converting Enzyme (Ace) Inhibitors, Angiotensin Ii Receptor Blockers (Arbs), Pirfenidone, Renin Inhibitors, Vasopeptidase Inhibitors, Other Treatment Types

2) By Diagnosis: Blood Tests, Urine Tests, Imaging Tests, Kidney Biopsy

3) By Application: Chronic Kidney Diseases, Kidney Cancer Treatment, Other Applications

4) By End-User: Clinics, Research Center, Hospitals

Subsegments:

1) By Angiotensin-Converting Enzyme (Ace) Inhibitors: Enalapril, Captopri, Lisinopril, Ramipril

2) By Angiotensin Ii Receptor Blockers (Arbs): Losartan, Telmisartan, Valsartan, Irbesartan

3) By Pirfenidone: Branded Pirfenidone, Generic Pirfenidone

4) By Renin Inhibitors: Aliskiren, Experimental Renin Inhibitors

5) By Vasopeptidase Inhibitors: Omapatrilat, Sampatrilat

6) By Other Treatment Types: Anti-Inflammatory Agents, Stem Cell Therapy, Antifibrotic Agents Under Clinical Trials, Gene Therapy

Which Companies Are Contributing Significantly To The Kidney Fibrosis Treatment Market Growth?

Major companies operating in the kidney fibrosis treatment market are F. Hoffman-La Roche Ltd., Merck & Co. Inc., Bayer AG, AstraZeneca PLC, Cara Therapeutics Inc., Gilead Sciences Inc., Novo Nordisk A/S, Boehringer Ingelheim International GmbH, Vertex Pharmaceuticals Incorporated, Chinook Therapeutics Inc., Reata Pharmaceuticals Inc., Akebia Therapeutics Inc., Travere Therapeutics Inc., Insilico Medicine Inc., Tvardi Therapeutics Inc., ProKidney LLC, Alentis Therapeutics AG, La Jolla Pharmaceutical Company, Galecto Biotech AB, Purespring Therapeutics Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/kidney-fibrosis-treatment-global-market-report

Which Region Offers The Most Opportunity For Kidney Fibrosis Treatment Market Expansion?

North America was the largest region in the kidney fibrosis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney fibrosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=24271&type=smp

Browse Through More Reports Similar to the Global Kidney Fibrosis Treatment Market 2025, By The Business Research Company

Kidney Transplant Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/kidney-transplant-global-market-report

Artificial Kidney Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/artificial-kidney-global-market-report

Rare Kidney Diseases Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rare-kidney-diseases-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795